Correlation Between Akari Therapeutics and Marizyme
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Marizyme, you can compare the effects of market volatilities on Akari Therapeutics and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Marizyme.
Diversification Opportunities for Akari Therapeutics and Marizyme
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Akari and Marizyme is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Marizyme go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Marizyme
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Marizyme. But the stock apears to be less risky and, when comparing its historical volatility, Akari Therapeutics PLC is 2.94 times less risky than Marizyme. The stock trades about -0.23 of its potential returns per unit of risk. The Marizyme is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 6.00 in Marizyme on September 1, 2024 and sell it today you would lose (1.00) from holding Marizyme or give up 16.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Marizyme
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Marizyme |
Akari Therapeutics and Marizyme Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Marizyme
The main advantage of trading using opposite Akari Therapeutics and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Marizyme vs. NRx Pharmaceuticals | Marizyme vs. RenovaCare | Marizyme vs. Aerovate Therapeutics | Marizyme vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |